Phase
Condition
Leukemia
Lymphoma, B-cell
Melanoma
Treatment
MB-CART19.1
MB-CART20.1
MB-CART2019.1
Clinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient underwent treatment with a Miltenyi CAR T cell therapy in one of the parenttrials at least 12 months prior to enrollment in long-term follow-up.
Patient has provided informed consent prior to enrollment.
Exclusion
Exclusion Criteria:
- No exclusion criteria
Study Design
Study Description
Connect with a study center
Charité Universitätsmedizin Berlin
Berlin 2950159, 13353
GermanyActive - Recruiting
Universitätsklinikum Köln
Cologne, 50937
GermanySite Not Available
Universitätsklinikum Köln
Cologne 2886242, 50937
GermanySite Not Available
Uniklinikum Erlangen
Erlangen 2929567, 91054
GermanySite Not Available
Universitätsmedizin Göttingen
Göttingen, 37075
GermanySite Not Available
Universitätsmedizin Göttingen
Göttingen 2918632, 37075
GermanySite Not Available
Universitätsklinikum Münster
Münster, 48149
GermanySite Not Available
Universitätsklinikum Münster
Münster 2867543, 48149
GermanyActive - Recruiting
Universitätsklinikum Tübingen
Tübingen 2820860, 72076
GermanySite Not Available
Universitäts-Kinderklinik Würzburg
Würzburg, 97080
GermanySite Not Available
Universitäts-Kinderklinik Würzburg
Würzburg 2805615, 97080
GermanySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.